FindTrial
Sign In

Epidemiological study of spinal metastases in China

Epidemiological study of spinal metastases in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-17013558
Enrollment
Unknown
Registered
2017-11-27
Start date
2017-11-15
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal metastases

Interventions

Case series:NA

Sponsors

Changzheng Hospital Affiliated to Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent; 2. Aged between 18 and 75 years; 3. Diagnosis of metastatic tumor of the spine.

Exclusion criteria

Exclusion criteria: 1. The objects refused to sign the informed consent; 2. The primary cancer site is central nervous system or spine; 3. The patients refused to be followed up; 4. Mental, intellectual disabilities or other communication disorders; 5. Any other do not conform the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
age;gender;location;pathological type;gene mutation;—

Countries

China

Contacts

Public ContactJianru Xiao

Changzheng Hospital Affiliated to Naval Medical University

jianruxiao83@163.com+86 13701785283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026